RMD ResMed Inc.
NYSE · Health Care · Surgical & Medical Instruments & Apparatus · Market cap $32.0B · $218.89 on 2026-10-02
On deckTier ADetailed (TTM)
Price moves
1 week-1%
1 month-4%
3 months4%
6 months-2%
YTD-13%
1 year-21%
Off 52w high-23%
52w range$180–$285
Price and total return
PriceTotal return (dividends reinvested)
Show year-end values
| Year | Price | Dividend-adjusted |
|---|---|---|
| 2016 | $62.05 | $55.86 |
| 2017 | $84.69 | $77.68 |
| 2018 | $113.87 | $105.94 |
| 2019 | $154.97 | $146.04 |
| 2020 | $212.56 | $202.02 |
| 2021 | $260.48 | $249.31 |
| 2022 | $208.13 | $200.77 |
| 2023 | $172.02 | $167.55 |
| 2024 | $228.69 | $224.83 |
| 2025 | $240.87 | $238.92 |
| 2026-10-02 (latest) | $218.89 | $218.89 |
Dividend-adjusted values are back-adjusted to today's price: the gap to the price column is the value of dividends reinvested since then.
Ten Cap
$113
$113
Buy (MOS)
$156
$156
Payback Time
$178
$178
Sticker
$313
$313
Price
$219
$219
Valuation
| Buy (MOS) 50% of Sticker | $156.45 | -29% |
|---|---|---|
| Ten Cap 10× owner earnings | $112.94 | -48% |
| Payback Time 8-year FCF payback | $178.29 | -19% |
| Sticker Rule #1 intrinsic value | $312.90 | 43% |
| Windage growth g | 15.0% | |
| Future P/E (min 2g, 10y median) | 30.0× | |
| P/E · 10y median | 21.0× | 40.9× |
| EPS TTM 2026-06-30 | $10.43 | |
| FCF yield | 5.2% | |
| Dividend (TTM) · yield | $2.46 | 1.1% |
| Dividend growth 5y, per year | 9.1% | |
| Total return per year, dividends reinvested · 5y · 10y | -2.7% | 14.9% |
| Revenue · net income last FY | $5.7B | $1.5B |
Big Five 12/15 tests ≥10%
| 10y | 5y | 1y | |
|---|---|---|---|
| ROIC | 17% | 20% | 21% |
| Sales growth | 12% | 12% | 10% |
| EPS growth | 15% | 26% | 10% |
| BVPS growth | 14% | 18% | 11% |
| OCF growth | 13% | 20% | 3% |
| Debt payoff (yrs of FCF) | 0.2 |
Events
-23% off 52w high; neg 8-K: 2026-08-17: Auditor change; next report ~2026-10-22
Next report ≈ 2026-10-22 · SEC filings ·Yahoo Finance
Research
- Rule #1 weekly scout, 4 Oct 2026 2026-10-04